235 Preliminary results of a stage orientated multimodality treatment including surgery for selected subgroups of limited disease small cell lung cancer (SCLC)
Wilfried Eberhardt(National Center for Tumor Diseases), S. Seeber, N Konietzko, Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), M. Flaßhove, S. Kolks(University of Duisburg-Essen), Martin Stuschke(Essen University Hospital), D Greschuchna(Ruhrlandklinik), Georgios Stamatis(Ruhrlandklinik), A. Harstrick(Merck KGaA, Darmstadt (Germany)), U. Klassen, H. Wilke(Heidelberg University), M.R. Mueller
Cited by 3
Related Papers
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
|The Lancet|2009|1.4k
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
|Journal of Clinical Oncology|2017|872
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
|Journal of Clinical Oncology|2010|714